Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Valproate-acid-induced cutaneous leukocytoclastic vasculitis (CROSBI ID 212699)

Prilog u časopisu | ostalo

Lasić, Davor ; Ivanišević, Ranka ; Uglešić, Boran ; Cvitanović Žuljan, Marija ; Glučina, Dubravka ; Hlevnjak, Ivana. Valproate-acid-induced cutaneous leukocytoclastic vasculitis // Psychiatria Danubina, 24 (2012), 2; 215-218. doi: 22706422

Podaci o odgovornosti

Lasić, Davor ; Ivanišević, Ranka ; Uglešić, Boran ; Cvitanović Žuljan, Marija ; Glučina, Dubravka ; Hlevnjak, Ivana.

engleski

Valproate-acid-induced cutaneous leukocytoclastic vasculitis

Valproate-induced vasculitis is seen as an adverse drug reaction in ratio that is less than 1/1000. Leukocytoclastic vasculitis can also occur internally. The cutaneous features of leukocytoclastic vasculitis are highly variable and may change rapidly. Valproic acid (VPA) is a chemical compound and an acid that has found clinical use as an anticonvulsant and mood-stabilizing drug, primarily in the treatment of epilepsy, bipolar disorder, and, less commonly, atypical depression with hypersomnia. A 35-year-old woman presented with purpuric papules on her lower extremities was admitted to the Department of Dermatology and Venerology, University Hospital Centre Split. Clinical recognition of drug-induced vasculitic is very important because continued use of the offending drug can lead to irreversible and life-threatening vasculitic organ damage (e.g. end-stage renal disease or pulmonary haemorrhage).

Valproate-acid; cutaneous leukocytoclastic vasculitis

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

24 (2)

2012.

215-218

objavljeno

0353-5053

1849-0867

22706422

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost